NCT01737372View on ClinicalTrials.gov

A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Multiple SclerosisSecondary Progressive Multiple SclerosisClinically Isolated Syndrome
Trial Locations (1)

84103

Rocky Mountain MS Clinic, Salt Lake City

All Listed Sponsors
collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

John F. Foley, MD

OTHER

NCT01737372 - A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis | Biotech Hunter | Biotech Hunter